Renal tubular dysfunction measured by N-acetyl-beta glucosaminidase/ Creatinine activity index in children receiving antiepileptic drugs: A randomized controlled trial

Italian Journal of Pediatrics

Volumn 37, Issue 1, 2011, Pages

  Mazaheri, Mojgan ^a   Samaie, Afshin ^a   Semnani, Vahid ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CREATININE; N ACETYL BETA GLUCOSAMINIDASE; VALPROIC ACID; ACETYLGLUCOSAMINIDASE; ANTICONVULSIVE AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EPILEPSY; FEMALE; HUMAN; KIDNEY TUBULE DISORDER; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; URINALYSIS; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FOLLOW UP; KIDNEY TUBULE; METABOLISM; PROGNOSIS; RISK FACTOR; URINE;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ANTICONVULSANTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CREATININE; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TUBULES; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL TUBULAR TRANSPORT, INBORN ERRORS; RISK FACTORS;

EID: 84860621035     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-37-21     Document Type: Article

References (19)

1. N-Acetyl-b-Glucosaminidase and b-Galactosidase Activity in Children Receiving Antiepileptic Drugs. Yüksel A, Cengiz M, Seven M, Cengiz S, Pediatr Neurol 2003 20 24 26
2. Asymptomatic children with epilepsy: Little benefit from screening for anticonvulsant induced liver, blood, or renal damage. Camfield C, Camfield P, Smith E, Tibbles JAR, Neurology 1986 36 838 841 3703292 (Pubitemid 16056227)
3. Effect of age on urinary excretion of N-acetyl-beta-D-glucosaminidase. Oba K, Hirai M, Ajiro Y, Okazaki K, Sato S, Sasai K, Suzuki T, Nakano H, Metori S, Nippon Ika Daigaku Zasshi 1999 66 33 36 1999 10.1272/jnms.66.33 10097588
4. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Price RG, Dance N, Richards B, Cattell WR, Clin Chim Acta 1970 27 65 72 10.1016/0009-8981(70)90375-X 5412613
5. Evaluation of renal tubular function in children taking anti-epileptic treatment. Unay B, Akin R, Sarici SU, Gok F, Kurt I, Gokcay E, Nephrology (Carlton) 2006 11 485 488 10.1111/j.1440-1797.2006.00699.x (Pubitemid 44951226)
6. The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Skálová S, Acta Medica (Hradec Kralove) 2005 48 75 80
7. Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine. Hurkacz M, Wiela-Hojeska A, Orzechowska-Juzwenko K, Kozik A, Unolt J, Pol Merkur Lekarski 2001 11 480 483 11899842
8. Increased urinary excretion of tubular enzymes and proteins in children with epilepsy. Korinthenberg R, Säger J, Zimmerhackl LB, Eur J Paediatr Neurol 2000 4 263 267 10.1053/ejpn.2000.0378 11277367
9. Urinary N-acetyl-beta-glucosaminidase and guanidinoacetic acid levels in epileptic patients treated with anti-epileptic drugs. Otsuka T, Sunaga Y, Hikima A, Brain Dev 1994 16 437 440 10.1016/0387-7604(94)90003-5 7694990
10. Urinary N-acetyl-beta-glucosaminidase (NAG) in children receiving antiepileptic drugs. Tseng CL, Wang PJ, Tsau YK, Lin MY, Shen YZ, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1992 33 251 256 1992 1296433
11. A new test to predict reversibility of hydronephrotic atrophy after stable partial unilateral ureteral obstruction. Huland H, Gonnermann D, Werner B, Possin U, J Urol 1988 140 1591 1594 2903939
12. Urinary excretion of tubular proteins and the technetium-99m dimercaptosuccinic acid (DMSA) absolute renal uptake in partial ureteral obstruction in rats: a functional evaluation of hydronephrotic kidneys. Everaert K, Van de Wiele C, Delanghe J, Vander Eecken H, Van Haelst JP, Van de Voorde J, Urol Res 1999 7 127 133 (Pubitemid 29227323)
13. Renal tubular dysfunction following treatment with anti-epileptic drugs. Korinthenberg R, Wehrle L, Zimmerhackl LB, Eur J Pediatr 1994 153 855 858 10.1007/BF01972897 7843203 (Pubitemid 24314760)
14. Coordinacy of lysosomal enzyme excretion in human urine. Paigen K, Peterson J, J Clin Invest 1978 61 751 762 10.1172/JCI108989 25285
15. Urinary excretion of N-acetyl b-glucosaminidase and b-galactosidase by patients with epilepsy. Novo MLP, Izumi T, Yokota K, Fukuyama Y, Brain Dev 1993 15 157 160 10.1016/0387-7604(93)90055-D 8214337 (Pubitemid 23185704)
16. Reliability of urinary N-acetyl-b-D glucosaminidase as an indicator of renal tubular damage in neonates. Watanabe K, Kojima T, Fukuda J, Biol Neonate 1987 52 16 21 10.1159/000242679 3620550 (Pubitemid 17092469)
17. Urinary N-acetyl-b-D glucosaminidase activities in patients with renal disease. Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF, BMJ 1975 3 408 411 10.1136/bmj.3.5980.408 1156788
18. Evaluation of renal tubular function in children taking anti-epileptic treatment. Unay B, Akin R, Sarici SU, Gok F, Kurt I, Gokcay E, Nephrology (Carlton) 2006 11 485 488 10.1111/j.1440-1797.2006.00699.x (Pubitemid 44951226)
19. Renal tubular function in patients receiving anticonvulsant therapy: a long-term study. Verrotti A, Greco R, Pascarella R, Matera V, Morgese G, Chiarelli F, Epilepsia 2000 41 1432 1435 10.1111/j.1528-1157.2000.tb00118.x 11077456